Michigan survey ahead; Applied Digital surges; gold dips - what’s moving markets
BETHESDA, Maryland - Medical imaging technology company Polarean Imaging plc (AIM:POLX) has received an order for its Xenon MRI System from the National Institutes of Health Clinical Center in Bethesda, Maryland, according to a company press release issued Thursday.
This marks the first system purchased directly from Polarean by the NIH, which operates the world’s largest hospital dedicated exclusively to clinical research.
The Xenon MRI System is designed for functional Magnetic Resonance Imaging of the lungs. The technology will enable the NIH Clinical Center to conduct high-performance polarization of Xenon for studies of innovative MRI techniques to better characterize lung disease.
The NIH Clinical Center, which opened in 1953, focuses on treating rare and severe diseases while conducting clinical research. The center serves as a facility for trials on rare diseases, experimental therapies, and medical research.
Dr. Christopher von Jako, CEO of Polarean, stated that the company will be working with Dr. Campbell-Washburn and her team at the NIH to conduct research on respiratory conditions.
Polarean Imaging is listed on London’s AIM market and specializes in commercial-stage medical imaging technology for lung function assessment using MRI.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.